- Home
- APLT vs MPV Comparison
APLT vs MPV Comparison
Compare APLT & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- MPV
- Stock Information
- Founded
- APLT 2016
- MPV 1988
- Country
- APLT United States
- MPV United States
- Employees
- APLT N/A
- MPV N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- MPV Finance Companies
- Sector
- APLT Health Care
- MPV Finance
- Exchange
- APLT Nasdaq
- MPV Nasdaq
- Market Cap
- APLT 178.6M
- MPV 201.1M
- IPO Year
- APLT 2019
- MPV N/A
- Fundamental
- Price
- APLT $1.05
- MPV N/A
- Analyst Decision
- APLT Buy
- MPV
- Analyst Count
- APLT 5
- MPV 0
- Target Price
- APLT $4.13
- MPV N/A
- AVG Volume (30 Days)
- APLT 11.8M
- MPV 25.2K
- Earning Date
- APLT 11-06-2025
- MPV 01-01-0001
- Dividend Yield
- APLT N/A
- MPV 8.71%
- EPS Growth
- APLT N/A
- MPV N/A
- EPS
- APLT N/A
- MPV 1.71
- Revenue
- APLT $121,000.00
- MPV N/A
- Revenue This Year
- APLT N/A
- MPV N/A
- Revenue Next Year
- APLT $5,931.24
- MPV N/A
- P/E Ratio
- APLT N/A
- MPV $9.35
- Revenue Growth
- APLT N/A
- MPV N/A
- 52 Week Low
- APLT $0.30
- MPV $11.18
- 52 Week High
- APLT $10.62
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- APLT 66.45
- MPV N/A
- Support Level
- APLT $0.56
- MPV N/A
- Resistance Level
- APLT $1.32
- MPV N/A
- Average True Range (ATR)
- APLT 0.17
- MPV 0.00
- MACD
- APLT 0.05
- MPV 0.00
- Stochastic Oscillator
- APLT 73.60
- MPV 0.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.